BHCM
HALO icon

Boulder Hill Capital Management’s Halozyme HALO Stock Holding History

Boulder Hill Capital Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-9,600
Closed -$367K – 126
2023
Q1 		$367K Buy
+9,600
New +$450K 0.3% 71
2022
Q4 		– Sell
-19,100
Closed -$755K – 175
2022
Q3 		$755K Buy
+19,100
New +$844K 0.57% 37

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Boulder Hill Capital Management's HALO Position: Q2 2023 in Review

Boulder Hill Capital Management sold out of Halozyme (HALO) in Q2 2023, closing a stake of 9,600 shares — an estimated $367K sold.

Boulder Hill Capital Management first reported a position in HALO in Q3 2022 and held it in 2 quarters. The position peaked at $755K in Q3 2022. 370 funds tracked by Wall St. Rank hold HALO as of Q2 2023.

  • Boulder Hill Capital Management reported no remaining Halozyme position as of Q2 2023 after selling out during the quarter.
  • Boulder Hill Capital Management sold 9,600 Halozyme shares in Q2 2023, an estimated $367K.
  • Boulder Hill Capital Management first reported a position in Halozyme in Q3 2022 and held it in 2 quarters.
  • Boulder Hill Capital Management's Halozyme position peaked at $755K in Q3 2022.
  • 370 funds tracked by Wall St. Rank held Halozyme as of Q2 2023.

Based on Boulder Hill Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.